OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Can we predict if patients with SLE will require more than one cycle of rituximab?
Raquel Fernández González, Rym Abida, Eugeniu Gisca, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. 1892-1899
Open Access | Times Cited: 4
Raquel Fernández González, Rym Abida, Eugeniu Gisca, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. 1892-1899
Open Access | Times Cited: 4
Showing 4 citing articles:
Systemic lupus erythematosus: history and modernity
Е. Л. Насонов, S. K. Soloviev, А. В. Аршинов
Rheumatology Science and Practice (2022) Vol. 60, Iss. 4, pp. 397-412
Open Access | Times Cited: 22
Е. Л. Насонов, S. K. Soloviev, А. В. Аршинов
Rheumatology Science and Practice (2022) Vol. 60, Iss. 4, pp. 397-412
Open Access | Times Cited: 22
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
Marlene Plüß, Silvia Piantoni, Björn Tampe, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 18
Marlene Plüß, Silvia Piantoni, Björn Tampe, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 18
Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update
Mia Rodziewicz, Claudia Mendoza‐Pinto, Sarah Dyball, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 65, pp. 152346-152346
Open Access | Times Cited: 3
Mia Rodziewicz, Claudia Mendoza‐Pinto, Sarah Dyball, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 65, pp. 152346-152346
Open Access | Times Cited: 3
Rituximab—a B cell targeted therapy in systemic lupus erythematosus: where do we stand?
Silvia Piantoni, Peter Korsten
Lara D. Veeken (2022) Vol. 61, Iss. 5, pp. 1752-1755
Closed Access | Times Cited: 2
Silvia Piantoni, Peter Korsten
Lara D. Veeken (2022) Vol. 61, Iss. 5, pp. 1752-1755
Closed Access | Times Cited: 2
